CVKDEarnings•businesswire•
Cadrenal Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Sentiment:Negative (10)
Summary
PONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #AFib--Cadrenal Therapeutics reports on Second Quarter 2025 financial results and provides corporate update on strategic clinical trial plans.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 11, 2025 by businesswire